Allison Pack, MPH

Research Associate, Social and Behavioral Health Sciences

Areas of expertise

  • HIV
  • Microbicides
  • Gender
  • Youth
  • Sexual and Reproductive Health

Projects & Resources

  • Should ongoing clinical trials identify an effective microbicide, the next challenge will be to ensure product access and use. Communication campaigns will play a critical role in generating demand and encouraging correct use.

  • FHI 360 developed and introduced innovative HIV prevention technologies — including microbicides and antiretrovirals — and worked with local partners to address the need for HIV prevention options, particularly for women.

Published Research

  • Positioning microbicides for HIV prevention in Kenya: A case study
    Ryan E, Bockh E, Tolley EE, Pack AP, Mackenzie C, Olawo A, Githuka G.
    Soc Mar Q 2015 Jun; 21 (2): 100-14. [Journal Impact Factor: n/a]

    This case study describes the experience of developing communication messages and materials to position microbicide gel — a product still in clinical trials — for HIV prevention in Kenya. The project confirmed that marketing microbicides to women in a wide variety of sexual contexts —and gaining the support of male partners — will be critical for avoiding stigmatization of the product. It also confirmed that the positioning of the product can impact interest in using microbicides and that in-depth counseling will be critical for ensuring correct use.

Explore More Related to Allison Pack, MPH